Johnson & Johnson
JNJ · FY2025 · Fiscal year ended Dec 28, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $94.2B | $88.8B | +6.0% |
| Operating income | $25.3B | $20.8B | +21.5% |
| Net income | $26.8B | $14.1B | +90.6% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 27, 2026 · filed Oct 21, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $25.4B | $24.0B | +5.9% |
| Operating income | $34.0M | $7.49B | −99.5% |
| Net income | $210M | $5.15B | −95.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was J&J's revenue in FY2025?
- $94.2B in FY2025 (Fiscal year ended Dec 28, 2025), +6.0% vs $88.8B a year earlier, per its 10-K filed Feb 2026.
- Was J&J profitable in FY2025?
- Yes: net income was $26.8B and operating income $25.3B in FY2025.
- What was J&J's revenue in Q3 2026?
- $25.4B (+5.9% vs a year earlier), per its Form 10-Q filed Oct 21, 2026.